Cantitate/Preț
Produs
Total produse
Vezi coșul
Handbook of Cancer Vaccines de Michael A. Morse

Handbook of Cancer Vaccines: Cancer Drug Discovery and Development

Editat de Michael A. Morse, Timothy M. Clay, H. Kim Lyerly
en Limba Engleză Hardback – 28 ian 2004
An authoritative survey of the scientific background for therapeutic cancer vaccines, the challenges to their development, and their current uses in treating cancer. The authors examine the basic issues that effect all vaccines (such as immune adjuvants and prime-boost strategies), describe the methods for antigen discovery, and review the preclinical development phases for each major vaccine strategy. They also spell out the clinical results for cancer vaccines now beginning to be used in the treatment of many common cancers.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 71992 lei  6-8 săpt.
  Humana Press Inc. – 24 iul 2012 71992 lei  6-8 săpt.
Hardback (1) 140133 lei  6-8 săpt.
  Humana Press Inc. – 28 ian 2004 140133 lei  6-8 săpt.

Din seria Cancer Drug Discovery and Development

  • 5% CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
    Preț: 143261 lei
  • 5% Developments in T Cell Based Cancer Immunotherapies
    Preț: 107654 lei
  • 5% mTOR Pathway and mTOR Inhibitors in Cancer Therapy
    Preț: 137506 lei
  • 5% Antiangiogenic Agents in Cancer Therapy
    Preț: 137017 lei
  • 5% Tumor Models in Cancer Research
    Preț: 141057 lei
  • 5% Telomeres and Telomerase in Cancer
    Preț: 131671 lei
  • 5% Gene Therapy for Cancer
    Preț: 139816 lei
  • 5% Proteasome Inhibitors in Cancer Therapy
    Preț: 108166 lei
  • 5% Oncogene-Directed Therapies
    Preț: 109393 lei
  • 24% Protein Tyrosine Kinases: From Inhibitors to Useful Drugs
    Preț: 103758 lei
  • 5% Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention
    Preț: 142423 lei
  • 5% Apoptosis, Senescence and Cancer
    Preț: 135076 lei
  • 5% Bioinformatics in Cancer and Cancer Therapy
    Preț: 137682 lei
  • 5% Bone Metastasis
    Preț: 108151 lei
  • 5% Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy
    Preț: 138752 lei
  • 5% Tumor Suppressor Genes in Human Cancer
    Preț: 138873 lei
  • 5% Platinum-Based Drugs in Cancer Therapy
    Preț: 75971 lei
  • 5% Regional Cancer Therapy
    Preț: 139727 lei
  • 5% Checkpoint Controls and Targets in Cancer Therapy
    Preț: 107844 lei
  • 5% Antifolate Drugs in Cancer Therapy
    Preț: 139319 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
    Preț: 136580 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology
    Preț: 141911 lei
  • 5% Farnesyltransferase Inhibitors in Cancer Therapy
    Preț: 107508 lei
  • 5% Supportive Care in Cancer Therapy
    Preț: 98217 lei
  • 5% Nucleic Acid Therapeutics in Cancer
    Preț: 70697 lei
  • 5% Stem Cells and Cancer
    Preț: 133174 lei
  • 5% EGFR Signaling Networks in Cancer Therapy
    Preț: 129738 lei
  • 5% Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics
    Preț: 109233 lei
  • 5% Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
    Preț: 139193 lei
  • 5% Hormone Therapy in Breast and Prostate Cancer
    Preț: 107900 lei
  • 5% Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications
    Preț: 131774 lei
  • 5% The Oncogenomics Handbook
    Preț: 142282 lei
  • 5% Macromolecular Anticancer Therapeutics
    Preț: 188387 lei
  • 5% Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions
    Preț: 137773 lei
  • 5% Cancer Drug Resistance
    Preț: 139761 lei
  • 5% Matrix Metalloproteinase Inhibitors in Cancer Therapy
    Preț: 106870 lei
  • 5% Fluoropyrimidines in Cancer Therapy
    Preț: 107810 lei
  • 5% In Vivo Imaging of Cancer Therapy
    Preț: 99056 lei
  • 5% The Tumor Microenvironment
    Preț: 140168 lei
  • 5% Camptothecins in Cancer Therapy
    Preț: 138787 lei
  • 5% Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
    Preț: 76502 lei
  • 5% Cancer Proteomics: From Bench to Bedside
    Preț: 131170 lei
  • 5% Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
    Preț: 133174 lei
  • 5% COX-2 Blockade in Cancer Prevention and Therapy
    Preț: 108116 lei
  • 5% Cytokines in the Genesis and Treatment of Cancer
    Preț: 139938 lei

Preț: 140133 lei

Preț vechi: 147508 lei
-5% Nou

Puncte Express: 2102
Preț estimativ în valută:
26816€ • 28204$ • 22407£

Carte tipărită la comandă

Livrare economică 08-22 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781588292094
ISBN-10: 1588292096
Pagini: 592
Ilustrații: XVIII, 592 p. 40 illus., 1 illus. in color.
Dimensiuni: 178 x 254 x 37 mm
Greutate: 1.24 kg
Ediția:2004
Editura: Humana Press Inc.
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

I: Basic Science of Tumor Antigens and Immune Activation.- 1 Biology of the Cancer Vaccine Immune Response.- 2 The Rational Design of T-Cell Epitopes With Enhanced Immunogenicity.- 3 Identification of Tumor Antigens Using Subtraction and Microarrays.- 4 Tumor Antigen Discovery With T Cells.- 5 Targeting Viral Antigens for the Treatment of Malignancies.- 6 Immune Defects in Cancer.- 7 Escape of Tumors From the Immune System: Role of the Transforming Growth Factor-ß-Signaling Pathway.- II: General Vaccine and Immunotherapy Strategies.- 8 Immune Adjuvants.- 9 Heterologous Prime-Boost Vaccination in Tumor Immunotherapy.- 10 Peptide-Based Vaccines.- 11 Antibody-Inducing Cancer Vaccines Against Cell-Surface Carbohydrate Antigens.- 12 Anti-Idiotype Vaccines.- 13 Pox Viral Vaccines.- 14 Utility of Adenovirus-Based Vectors for Multiple Cancer Vaccine Approaches.- 15 Alphaviral-Based Strategies for the Immunotherapy of Cancer.- 16 DNA Vaccines.- 17 Whole-Cell Vaccines.- 18 Gene-Modified Tumor-Cell Vaccines.- 19 Hapten-Modified Tumor Vaccines.- 20 Chaperone Proteins/Heat Shock Proteins As Anticancer Vaccines.- 21 Dendritic Cell Vaccines.- 22 Exosomes for Immunotherapy of Cancer.- 23 Immunocytokines for Cancer Immunotherapy.- 24 T-Cell Adoptive Immunotherapy.- III: Tumor-Specific Vaccine Development.- 25 Melanoma Vaccines.- 26 Allogenic Melanoma Lysate Vaccines.- 27 Renal Cancer Vaccines.- 28 Vaccines for Hematological Malignancies.- 29 Vaccines for the Immunotherapy of Prostate Cancer.- 30 Vaccine Therapy for Breast and Ovarian Cancers.- 31 Vaccine Therapy for Gastrointestinal Cancers.- 32 Vaccines for Lung Cancer.- 33 Vaccines for Other Tumors.- IV: Clinical Trials and Immune Analyses.- 34 Clinical Trial Designs for Therapeutic Vaccine Studies.- 35 Analysis of Cellular ImmuneResponses in Cancer Vaccine Trials.- 36 Analysis of Humoral Immune Responses in Vaccine Trials.- 37 Regulatory Issues Affecting Tumor Vaccines.

Recenzii

"This is an excellent resource for anyone interested in tumor immunotherapy. It is truly a comprehensive review of vaccination strategies for the treatment of cancer. The third section looks at the results of vaccine-based clinical trials for various malignancies. This section is an exceptional reference for oncologists. The chapters on melanoma are particularly helpful in sorting through the saga of vaccination for this deadly disease. The concluding section, important for clinical researchers, focuses on clinical trial design, the analysis of immune responses, and vaccine regulatory issues. " -Doody's Health Sciences Book Review Journal

"Highly recommended for medical schools and hospital libraries." - E-STREAMS

"...Comprehensive and authoritative...makes available to medical oncologists and immunologists a cutting-edge synthesis of the scientific rationale, preclinical data, and clinical results for the powerful new generation of vaccines now under development and treatment of a wide range of human cancers." - Tumori

Textul de pe ultima copertă

The quest to harness the immune system for the treatment of cancer has been of great interest for more than 100 years, but new discoveries illuminating the requirements for immune activation and recognition of cancers have greatly increased the promise of reaching this goal. In Handbook of Cancer Vaccines, leading scientific investigators and clinicians distill the vast body of literature on cancer vaccines to create an authoritative survey of the scientific background for such therapeutic vaccines, the challenges to their development, and their current uses in treating cancer. The authors examine the basic issues that affect all vaccines (such as immune adjuvants and prime-boost strategies), describe cutting-edge methods for antigen discovery, and review the preclinical development phases for each major vaccine strategy. Topics of particular interest include the clinical results for cancer vaccines now beginning to be used in the treatment of many common cancers, the monitoring of biologic responses to these vaccines, and the statistical and regulatory issues affecting the design and conduct of their clinical trials.
Comprehensive and authoritative, the Handbook of Cancer Vaccines makes available to medical oncologists and immunologists a cutting-edge synthesis of the scientific rationale, preclinical data, and clinical results for the powerful new generation of vaccines now under development for the treatment of a wide range of human cancers.

Caracteristici

Includes supplementary material: sn.pub/extras